Tesla (TSLA) shares surged 7.6% on Wednesday, just a week ahead of its Q1 earnings report, despite cautious outlooks from analysts at Barclays and TD Cowen. Cowen, while lowering its price target to $490, maintains a buy rating, suggesting that lowered expectations following a recent delivery miss could work in Tesla’s favor. Conversely, Barclays is more pessimistic, setting a $360 price target and raising concerns about the potential costs associated with Tesla’s new “Terafab” chip venture, which could significantly impact cash flow and earnings.
The mixed sentiment reflects a broader uncertainty in the market regarding Tesla’s growth trajectory. Analysts are projecting a sales increase of 17% for the quarter, estimating revenues of at least $22.6 billion and a per-share profit of $0.38, a notable rise from the previous year. However, concerns over capital expenditures could overshadow these optimistic sales forecasts.
As earnings season approaches, the key takeaway for investors is to closely monitor how Tesla balances its ambitious spending plans with the need to maintain profitability.
Source: fool.com